Table 2.
Whole | Non-Obese | Obese | |||||||||||
Controls (305) | Diabetic patients (342) | Controls (228) | Diabetic patients (162) | Controls (77) | Diabetic patients (180) | ||||||||
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | ||
UCP2 | A/A | 34 | 11 | 30 | 9 | 22 | 10 | 15 | 9 | 12 | 16 | 15 | 8 |
G/A | 124 | 41 | 145 | 42 | 95 | 42 | 70 | 43 | 29 | 38 | 75 | 42 | |
G/G | 147 | 48 | 167 | 49 | 111 | 49 | 77 | 48 | 36 | 47 | 90 | 50 | |
UCP3 | C/C | 224 | 73 | 240 | 70 | 165 | 72 | 106 | 65 | 59 | 77 | 134 | 74 |
C/T | 78 | 26 | 94 | 27 | 61 | 27 | 49 | 30 | 17 | 22 | 45 | 25 | |
T/T | 3 | 1 | 8 | 2 | 2 | 1 | 7 | 4 | 1 | 1 | 1 | 1 | |
ADRB1 | Arg/Arg | 139 | 46 | 167 | 49 | 100 | 44 | 81 | 50 | 39 | 51 | 86 | 48 |
Gly/Arg | 134 | 44 | 136 | 40 | 103 | 45 | 63 | 39 | 31 | 40 | 73 | 41 | |
Gly/Gly | 32 | 10 | 39 | 11 | 25 | 11 | 18 | 11 | 7 | 9 | 21 | 12 | |
ADRB2-16 | Arg/Arg | 49 | 16 | 68 | 20 | 35 | 15 | 28 | 17 | 14 | 18 | 40 | 22 |
Arg/Gly | 126 | 41 | 149 | 44 | 92 | 40 | 71 | 44 | 34 | 44 | 78 | 44 | |
Gly/Gly | 130 | 43 | 124 | 36 | 101 | 44 | 63 | 39 | 29 | 38 | 61 | 34 | |
ADRB2-27 | Gln/Gln | 135 | 44 | 172 | 50 | 99 | 43 | 72 | 44 | 36 | 47 | 100 | 56 |
Gln/Glu | 124 | 41 | 138 | 40 | 98 | 43 | 71 | 44 | 26 | 34 | 67 | 37 | |
Glu/Glu | 46 | 15 | 31 | 9 | 31 | 14 | 19 | 12 | 15 | 19 | 12 | 7 |